This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H1N1 Hemagglutinin (HA), N-His
Product Overview
BioVenic's Recombinant Influenza A H1N1 Hemagglutinin (HA), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 27.5 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Hemagglutinin is a vital Class I surface glycoprotein of the Influenza A H1N1 virus, mediating viral entry into host cells. It functions by binding to sialic acid receptors on the host cell membrane, triggering receptor-mediated endocytosis. Subsequent acidification of the endosome induces a conformational change in HA, facilitating membrane fusion. As a primary target for neutralizing antibodies, HA is the central component in vaccine development and a key focus for entry-inhibitor therapeutics aimed at preventing seasonal and pandemic flu.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.